KPV
KPV is the C-terminal tripeptide fragment of α-MSH with anti-inflammatory properties, and people run it mostly for gut healing and systemic inflammation; skin and wound use is reported but the captured results are mixed. In practice, users dose once or twice daily on variable cycles, while clinician sources typically recommend 200–500 mcg twice daily for four to eight weeks. There is no FDA-approved indication, so all human use is off-label and compounded, and the entire evidence base rests on preclinical work and a small community corpus.
Research Evidence
Evidence shape
KPV sits at the animal-only tier; there is no human evidence behind it. The entire mapped literature spans a single indication area, limited strictly to preclinical mechanistic research in animals, and not one trial has been completed or registered. That leaves no blinded studies, no posted results, and a total absence in the human safety and efficacy record; the blank itself is the only signal the literature provides.
Anecdotal efficacy
Side effects
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How KPV is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
- Frequency
- BID
- Timing
- unspecified
- Route
- subQ
- Cycle
- unspecified
Clinician protocols dose 200 µg–500 µg BID subQ (4 sources).
No structured protocol details captured for this tier yet.
Anecdotal reports highlight KPV's effects for gut healing and digestive issues (3 of 4 reports positive), systemic inflammation and pain (4 of 4 reports positive), and skin conditions and wound healing (2 of 2 reports positive). No specific dose hints were provided in community posts.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Peptide feedback
0 forum repliesLive community discussion for KPV, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.